CHENG Yuan, GENG Haiyuan, HUA Haiqing. Multi-line Treatment Combined Apatinib with Toptecan for Platinum-resistant Recurrent Ovarian Cancer: Two Cases Report[J]. Cancer Research on Prevention and Treatment, 2018, 45(3): 188-190. DOI: 10.3971/j.issn.1000-8578.2018.17.0690
|
Citation:
|
CHENG Yuan, GENG Haiyuan, HUA Haiqing. Multi-line Treatment Combined Apatinib with Toptecan for Platinum-resistant Recurrent Ovarian Cancer: Two Cases Report[J]. Cancer Research on Prevention and Treatment, 2018, 45(3): 188-190. DOI: 10.3971/j.issn.1000-8578.2018.17.0690
|
CHENG Yuan, GENG Haiyuan, HUA Haiqing. Multi-line Treatment Combined Apatinib with Toptecan for Platinum-resistant Recurrent Ovarian Cancer: Two Cases Report[J]. Cancer Research on Prevention and Treatment, 2018, 45(3): 188-190. DOI: 10.3971/j.issn.1000-8578.2018.17.0690
|
Citation:
|
CHENG Yuan, GENG Haiyuan, HUA Haiqing. Multi-line Treatment Combined Apatinib with Toptecan for Platinum-resistant Recurrent Ovarian Cancer: Two Cases Report[J]. Cancer Research on Prevention and Treatment, 2018, 45(3): 188-190. DOI: 10.3971/j.issn.1000-8578.2018.17.0690
|
DownLoad: